Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: A randomized, double-blind, placebo-controlled trial

Journal of Reproductive Medicine

Volumn 58, Issue 1-2, 2013, Pages 39-46

  Kohama, Takafumi ^a   Negami, Masako ^a  

^a Keiju Medical Center   (Japan)

Author keywords

Climacteric; Kupperman's index; Perimenopause; Pycnogenol; Women's Health Questionnaire

Indexed keywords

ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; PRASTERONE SULFATE; PYCNOGENOL; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ABDOMINAL CRAMP; ADULT; ANXIETY; ARTICLE; BREAST TENDERNESS; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; EMPLOYMENT; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MEMORY DISORDER; MENOPAUSAL SYNDROME; MYALGIA; NERVOUSNESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VASOMOTOR DISORDER;

ADULT; ANALGESICS; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; HOT FLASHES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PERIMENOPAUSE; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 84873874715     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mishra GD, Kuh D: Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ 2012;344:e402
2. Spencer RP: Cessation of reproduction: An analytic view of menopause. Med Hypotheses 2002;59:406-410
3. Zapantis G, Santoro N: The menopausal transition: Characteristics and management. Best Pract Res Clin Endocrinol Metab 2003;17:33-52
4. Wu JM, Zelinski MB, Ingram DK, et al: Ovarian aging and menopause: Current theories, hypotheses, and research models. Exp Biol Med (Maywood) 2005;230:818-828
5. Geller SE, Studee L: Contemporary alternatives to plant estrogens for menopause. Maturitas 2006;55:3-13
6. Yang HM, Liao MF, Zhu SY, et al: A randomised, doubleblind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women. Acta Obstet Gynecol Scand 2007;86:978-985
7. Nishioka K, Hidaka T, Nakamura S, et al: Pycnogenol, French maritime pine bark extract, augments endotheliumdependent vasodilation in humans. Hypertens Res 2007;30: 775-780
8. Grimm T, Chovanová Z, Muchová J, et al: Inhibition of NFkappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (Lond) 2006;3:1
9. Canali R, Comitato R, Schonlau F, et al: The anti-inflammatory pharmacology of Pycnogenol in humans involves COX-2 and 5-LOX mRNA expression in leukocytes. Int Immunopharmacol 2009;9:1145-1149
10. Kohama T: Clinical applications of Pycnogenol in Japan. Prog Med 2004;24:1503-1510
11. Kohama T, Inoue M: Pycnogenol alleviates pain associated with pregnancy. Phytother Res 2006;20:232-234
12. Kohama T, Herai K, Inoue M: Effect of French maritime pine bark extract on endometriosis as compared with leuprorelin acetate. J Reprod Med 2007;52:703-708
13. Suzuki N, Uebaba K, Kohama T, et al: French maritime pine bark extract significantly lowers the requirement for analgesic medication in dysmenorrhea: A multicenter, randomized, double-blind, placebo-controlled study. J Reprod Med 2008;53:338-346
14. Hunter MS: The Women's Health Questionnaire (WHQ): Frequently Asked Questions (FAQ). Health Qual Life Outcomes 2003;1:41
15. Abe T, Suzuki M, Moritsuka T, et al: Statistical factor analysis and cluster analysis in the etiology of climacteric symptoms. Tohoku J Exp Med 1984;143:481-489
16. Rohdewald P: A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 2002;40:158-168
17. Enseleit F, Sudano I, Périat D, et al: Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: A double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J 2012;33:1589-1597
18. Charkoudian N, Stephens DP, Pirkle KC, et al: Influence of female reproductive hormones on local thermal control of skin blood flow. J Appl Physiol 1999;87:1719-1723
19. Deecher DC, Dorries K: Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health 2007;10:247-257
20. Thurston RC, El Khoudary SR, Sutton-Tyrrell K, et al: Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation. Menopause 2011;18: 1044-1051
21. Kronenberg F, Fugh-Berman A: Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials. Ann Intern Med 2002;137:805-813
22. Errichi S, Bottari A, Belcaro G, et al: Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. Panminerva Med 2011;53:65-70